We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
Turnover
4.07%
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+14.09%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$6.18T
AUM Growth
+$647B
(+12%)
Cap. Flow
+$78.1B
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
4,383
New
103
Increased
2,425
Reduced
1,410
Closed
108
Avg Time Held
8.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.95B |
| 2 |
NVIDIA
NVDA
|
+$4.97B |
| 3 |
Capital One
COF
|
+$4.5B |
| 4 |
Amazon
AMZN
|
+$3.45B |
| 5 |
Flutter Entertainment
FLUT
|
+$3.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Discover Financial Services
DFS
|
+$5.32B |
| 2 |
Intra-Cellular Therapies Inc.
ITCI
|
+$1.26B |
| 3 |
Amphenol
APH
|
+$1.18B |
| 4 |
Welltower
WELL
|
+$987M |
| 5 |
US Steel
X
|
+$825M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.14% |
| 2 | Financials | 14% |
| 3 | Consumer Discretionary | 10.14% |
| 4 | Healthcare | 9.38% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
Vor Biopharma
VOR
$1.14B
| $3.1M | ﹤0.01% |
95,780
-1,231
| -1% | -$10.9K |
2021 Q1
17 quarters
|
|
3377
Orchestra BioMed
OBIO
$345M
| $3.1M | ﹤0.01% |
1,157,317
-150,449
| -12% | -$439K |
2023 Q1
9 quarters
|
|
3378
iShares Core S&P Small-Cap ETF
IJR
$103B
| $3.1M | ﹤0.01% |
28,337
-443
| -2% | -$45.8K |
2023 Q1
9 quarters
|
|
3379
Monopar Therapeutics
MNPR
$482M
| $3.09M | ﹤0.01% |
86,489
+31,255
| +57% | +$1.14M |
2024 Q4
2 quarters
|
|
3380
Alpha Pro Tech
APT
$58.4M
| $3.09M | ﹤0.01% |
659,531
| – | – |
2014 Q4
42 quarters
|
|
3381
First Northwest Bancorp
FNWB
$91.6M
| $3.07M | ﹤0.01% |
398,961
-7,546
| -2% | -$69.8K |
2015 Q1
41 quarters
|
|
3382
DELISTED
NSTS Bancorp
NSTS
| $3.06M | ﹤0.01% |
248,312
+6,719
| +3% | +$80.3K |
2022 Q1
13 quarters
|
|
3383
Ocean Power Technologies
OPTT
$6.19M
| $3.03M | ﹤0.01% |
212,858
+4,314
| +2% | +$61.4K |
2019 Q2
24 quarters
|
|
3384
Siebert Financial
SIEB
$82.4M
| $3.03M | ﹤0.01% |
685,657
+297,632
| +77% | +$1.21M |
2017 Q4
30 quarters
|
|
3385
Smart Sand
SND
$215M
| $2.99M | ﹤0.01% |
1,486,215
+23,585
| +2% | +$47.7K |
2016 Q4
34 quarters
|
|
3386
Hycroft Mining Holding Corp
HYMC
$1.62B
| $2.99M | ﹤0.01% |
954,240
+160,310
| +20% | +$524K |
2020 Q3
19 quarters
|
|
3387
DELISTED
SWK Holdings
SWKH
| $2.96M | ﹤0.01% |
201,058
-93,239
| -32% | -$1.32M |
2020 Q2
20 quarters
|
|
3388
Firy Inc
FIRY
$192M
| $2.96M | ﹤0.01% |
434,449
| – | – |
2021 Q1
17 quarters
|
|
3389
Contineum Therapeutics
CTNM
$297M
| $2.95M | ﹤0.01% |
744,001
-59,427
| -7% | -$258K |
2024 Q2
4 quarters
|
|
3390
Summit State Bank
SSBI
$83.1M
| $2.95M | ﹤0.01% |
272,094
-5,830
| -2% | -$54K |
2013 Q4
46 quarters
|
|
3391
Sutro Biopharma
STRO
$190M
| $2.94M | ﹤0.01% |
411,525
-27,999
| -6% | -$229K |
2018 Q4
26 quarters
|
|
3392
Amtech Systems
ASYS
$235M
| $2.93M | ﹤0.01% |
658,907
-11,877
| -2% | -$46.4K |
2013 Q2
48 quarters
|
|
3393
First Capital
FCAP
$206M
| $2.92M | ﹤0.01% |
70,746
+25,225
| +55% | +$1.13M |
2017 Q4
30 quarters
|
|
3394
Team
TISI
$112M
| $2.91M | ﹤0.01% |
159,903
+10,802
| +7% | +$218K |
2013 Q2
48 quarters
|
|
3395
Tenaya Therapeutics
TNYA
$91.6M
| $2.91M | ﹤0.01% |
4,755,327
+673,295
| +16% | +$343K |
2021 Q3
15 quarters
|
|
3396
DELISTED
Monogram Orthopaedics
MGRM
| $2.9M | ﹤0.01% |
1,004,788
+108,090
| +12% | +$291K |
2024 Q2
4 quarters
|
|
3397
Mercer International
MERC
$13.4M
| $2.9M | ﹤0.01% |
828,206
+3,595
| +0.4% | +$14.9K |
2013 Q2
48 quarters
|
|
3398
GSI Technology
GSIT
$165M
| $2.9M | ﹤0.01% |
861,829
+5,158
| +0.6% | +$15.7K |
2013 Q2
48 quarters
|
|
3399
Navigator Holdings
NVGS
$1.35B
| $2.89M | ﹤0.01% |
+204,454
| New | +$2.75M |
2025 Q2
0 quarters
|
|
3400
Unicycive Therapeutics
UNCY
$100M
| $2.89M | ﹤0.01% |
605,953
+484,709
| +400% | +$3M |
2021 Q4
14 quarters
|
|
Similar funds
Vanguard Group's Q2 2025 Portfolio in Review
As of Q2 2025, Vanguard Group held 4,383 positions worth $6.18T, up 12% from $5.53T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2025: portfolio turnover was 4.8%. Vanguard Group opened 103 new positions and exited 108, leaving the 4,383-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q2 2025 buy was Amrize Ltd: 21,350,540 shares worth $1.07B.
- Vanguard Group added most to Microsoft in Q2 2025, an estimated $5.95B increase.
- Vanguard Group's biggest Q2 2025 reduction was Amphenol, cutting an estimated $1.18B.
- Vanguard Group fully exited Discover Financial Services in Q2 2025, selling an estimated $5.32B.
- Vanguard Group's ten largest holdings make up 29% of its $6.18T portfolio in Q2 2025.
- Vanguard Group opened 103 new positions and closed 108 in Q2 2025.
- Vanguard Group's portfolio value rose 12% quarter-over-quarter to $6.18T.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.